Pharmacy Coord Oncology and Sterile Compounding

Brown Medicine•Cranston, RI

4d•Onsite

About The Position

Reporting to the Pharmacy Manager, Oncology and Sterile Compounding, the Pharmacy Coordinator, Oncology and Sterile Compounding is responsible for coordinating operations and processes relating to oncology and compounded sterile products (CSPs) at Rhode Island Hospital (RIH). This includes making recommendations for operational changes, allocation of resources, and new technologies that will increase the efficiency and level of service of the pharmacy. Monitors compliance with regulations and regulatory boards as related to compounding of sterile pharmaceuticals [i.e., Rhode Island Department of Health, Rhode Island Board of Pharmacy Rules and Regulations, United States Pharmacopoeia (USP) Chapter <797> Pharmaceutical Compounding – Sterile Preparations, USP <800> Hazardous Drugs, National Institute for Occupational Safety and Health (NIOSH), and The Joint Commission (TJC) Medication Management chapter]. Serves as one of the “designated persons” assigned by the facility (Rhode Island Hospital) to be responsible and accountable for the performance and operation of the facility and personnel for the preparation of compounded sterile preparations (CSPs), in accordance with USP Chapter <797>. Serves as the “designated person” assigned by the facility (Rhode Island Hospital) to be responsible for the oversight of monitoring the facility and maintaining compliance with USP Chapter <800>. In addition, the incumbent performs the duties of a Clinical Pharmacist.

Requirements

Bachelor of Science in Pharmacy or Doctor of Pharmacy degree from an accredited college of pharmacy.
Prior to start date, possesses current unrestricted licensure as a licensed pharmacist or as a licensed 90-day temporary pharmacist in the State of Rhode Island.
Obtains full licensure prior to expiration of 90-day temporary pharmacist license, then possesses and maintains current unrestricted licensure as licensed pharmacist in the State of Rhode Island.
Must possess and maintains current American Heart Association Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) Certifications within 90 days of start date.
Demonstrates knowledge and skills necessary to provide care to neonate, child, adolescent, adult, and geriatric patients with consideration of aging processes, human development stages and cultural patterns in each step of the care process.
Three years progressively more responsible related experience, preferably gained in a similarly diverse and operationally complex health care environment is desired.
Knowledge of pharmacy information systems, automated dispensing technology and personal computers.
Demonstrates excellent written and verbal interpersonal and communication skills

Responsibilities

Is responsible for knowing and acting in accordance with the principles of the Brown University Health Corporate Compliance Program and Code of Conduct.
In addition to position specific responsibilities of a Clinical Pharmacist, the Pharmacy Coordinator, Oncology and Sterile Compounding shall be responsible for the following:
Coordinates and provides oversight to operations and processes relating to oncology and compounded sterile product services in accordance with existing hospital policies, procedures, and standards of practice.
Serves as the primary “designated person” assigned by Rhode Island Hospital to be responsible and accountable for the operation and performance of the compounding facility and personnel, in accordance with USP Chapter <797>.
Serves as the primary “designated person” assigned by Rhode Island Hospital to be responsible for standard operating procedure (SOP) development, personnel competency oversight, and ensuring facility and environmental testing compliance in accordance with USP Chapter <800>.
When staffing, is accessible as a resource to pharmacist and technician staff members performing sterile compounding activities.
Participates in emergency code blue response when staffing.
Provides oversight to personnel training, monitoring of aseptic processing environments, and competency evaluations of garbing, aseptic work practices, and cleaning / disinfection procedures.
Serves as a liaison between pharmacy and hospital staff for integration of sterile compounding activities and regulatory compliance.
Provides input on the development of policies and procedures related to sterile compounding and oncology services.
Provides input on safety events related to sterile compounding and oncology services in order to minimize risk of reoccurrence.
Continually reviews and analyzes operations recommending and implementing operational changes, allocation of resources, new technologies etc. that will increase efficiency and the level of sterile compounding and oncology services.
Maintains specialized equipment and technologies utilized in the preparation of CSPs, including oncology medications.
Ensures personnel are appropriately trained on all equipment.
Participates in the development of tools and standards to establish and improve competency level of the staff in the areas of CSPs and oncology services.
Participates in the quality and compliance review of third-party offsite compounding pharmacies providing contracted services that include sterile compounded products.
Participates in the development of continuous quality improvement initiatives in the areas of compounded sterile and oncology services.
Continually designs and reviews compounding master formulation worksheets in LifeChart and Formulations program, sharing suggestions for revisions and additions across affiliates.
Evaluates and recommends technologies, physical designs, procedures, and techniques to maintain the hospital's level of compliance with USP Chapter <797> &<800> standards including but not limited to continuous and on-going compliance monitoring.
Evaluates and recommends technologies, physical designs, procedures, and techniques to increase level of compliance with TJC Medication Management chapter as it relates to sterile compounding and oncology services.
TJC requires pharmacy to provide all intravenous medications in a ready to administer form except in very limited circumstances.